ITGAM and Alzheimer disease: Our results indicated that TAK-242 treatment resulted in an increase in CD11b-positive cells expressing M2 markers and a significant decrease in the level of M1 markers in AD transgenic model and that microglia exhibited more ameboid-shaped microglia with enlarged soma and thickened processes, highlighting the protective role of TAK-242.